Royan Stem Cell Technology Company

What Royan Stem Cell Technology Company does

Royan Stem Cell Technology Company is an Iranian biotechnology company headquartered in Tehran that operates the first private and public cord blood stem cell bank in Iran and claims to be the largest cord blood bank in the Middle East. Founded in 2005, the company collects, processes, tests, and cryopreserves newborn cord blood stem cells in liquid nitrogen tanks at -196°C, and has accumulated over 230,000 stored samples over approximately two decades of operation. It also stores peripheral blood, dental pulp, umbilical cord tissue, HLA-typed units, and cord blood plasma under an integrated multi-bank system at its headquarters.

The company's product portfolio spans four categories: core stem cell banking subscriptions (cord blood, peripheral blood, dental pulp, umbilical cord tissue), cellular products (mesenchymal stem cells, cord blood cells, PRP) sold to hospitals and transplant centers, advanced bio-materials (placenta derivatives, amniotic membrane dressings, human cord blood serum, eye serum drops) produced at what it describes as the first umbilical cord by-product processing refinery in the Middle East, and fee-for-service laboratory offerings (flow cytometry, cell processing, microbiology testing). It distributes through a direct-to-consumer website portal (portal.rsct.ir), a 46-agency network across Iranian provinces, and hospital partnerships for in-delivery sample collection.

Revenue is generated primarily through recurring annual private cord blood storage subscriptions paid by expectant parents, supplemented by transactional sales of cellular products and bio-materials to healthcare providers, and fee-for-service laboratory work. The company is affiliated with Royan Research Institute, which provides access to clinical and scientific expertise, and has executed hospital partnerships (e.g., Shafa Hospital in Ahvaz, 2025) for joint stem cell transplant procedures. It has supported over 30 successful transplants from its stored inventory and more than 150 cerebral palsy cases under clinical trial use.

Name

Royan Stem Cell Technology Company

Legal name

Royan Stem Cell Technology Company (شرکت فناوری بن یاخته‌های رویان)

Website

https://rsct.ir

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

51–100 employees

Short description

Royan Stem Cell Technology Company is Iran's first private and public cord blood stem cell bank, collecting, processing, and cryopreserving newborn stem cells for expectant parents and supplying cellular products, bio-materials, and laboratory services to Iranian hospitals and research institutions.

Ownership category

akta.pro rank

Product category

Cord Blood Stem Cell Banking

NAICS

Blood and Organ Banks (621991)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

akta.pro secondary industries

Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low) (HLAGAGAK), Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies (HLAAAJAN)

Keywords

• Cord blood banking
• Stem cell storage
• Regenerative medicine
• Cellular therapy products
• Bio-material processing

Headquarters

HQ city

Tehran

HQ country

Iran

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Supply Chain, Marketing or Sales

Revenue model

1. Private Cord Blood Banking (Annual Subscription): Families pay registration fees and annual renewal charges for private storage of their newborn's cord blood stem cells. Samples are owned by the contracting party and kept until they choose to use or donate them. Annual charging is done through the company's website.
2. Cellular Products Sales: Sale of mesenchymal stem cells, cord blood cells, and PRP products to transplant centers and healthcare providers.
3. Laboratory Services: Fee-for-service laboratory testing including flow cytometry, processing laboratory, and microbiology services for external clients.
4. Bio-materials (Placenta, Amniotic Membrane, Cord Blood Serum): Sale of advanced bio-materials derived from birth-related tissues including placenta, amniotic membrane dressings, human cord blood serum, and eye serum drops.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Royan Stem Cell Technology Company collects, processes, tests, and cryopreserves newborn cord blood stem cells at -196°C in liquid nitrogen tanks for private and public banking. It also produces and distributes cellular therapeutic products (mesenchymal stem cells, cord blood cells, PRP), advanced bio-materials from birth-related tissues (placenta, amniotic membrane dressings, cord blood serum, eye serum drops), and offers specialized laboratory services including flow cytometry, cell processing, and microbiology testing.

Product overview

Royan Stem Cell Technology Company operates as Iran's first private and public cord blood stem cell bank, serving as the largest cord blood bank in the Middle East. The company offers a comprehensive portfolio of stem cell banking services including cord blood banking, peripheral blood banking, dental pulp banking, and umbilical cord tissue banking under its stem cell storage bank division. Its cellular products include mesenchymal stem cells, cord blood cells, and PRP. The advanced biomaterials division produces placenta products, amniotic membrane dressings, human cord blood serum, and eye serum drops. The company also operates specialized laboratories for flow cytometry, cell processing, and microbiology testing, along with a birth by-products purification facility. With over 250,000 stored samples across 46 branches nationwide, the company has performed more than 30 successful transplants.

Differentiator

Problem solved

Functional benefit

Products and services

• Bank of Cord Blood
• Bank of Peripheral Blood
• Dental Pulp Bank
• Umbilical Cord Tissue Bank
• Mesenchymal Stem Cells
• Cord Blood Cells
• PRP (Platelet-Rich Plasma)
• Placenta (Bio-material)
• Amniotic Membrane Dressing
• Human Cord Blood Serum
• Eye Serum Drop
• Flow Cytometry Laboratory Services
• Processing Laboratory Services
• Microbiology Laboratory Services
• Purification Facility for Birth By-products

Quantifiable outcome

• 30+ successful transplants using stored cord blood samples
• +3 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Two partnerships are on record, tiered core and moderate.

• Shafa Hospital, Ahvaz (بیمارستان شفا اهواز)coreStrategic or Co-development Partner · 23 June 2025A successful autologous stem cell transplant was performed for a 16-year-old patient suffering from Non-Hodgkin Lymphoma in Ahvaz, in joint collaboration between Royan Stem Cell Technology Company and Shafa Hospital Ahvaz. This is a reference hospital partnership for stem cell transplant procedures.
• Jahad Daneshgahi of Markazi Province (جهاد دانشگاهی استان مرکزی)moderateStrategic or Co-development Partner · 18 June 2025Senior officials of Royan Cord Blood Bank met with the head of Jahad Daneshgahi (Scientific-Applied University) of Markazi Province. The head emphasized strengthening mutual cooperation between the two organizations. This represents a regional government-academic partnership for potential collaboration in stem cell services.

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• Mesoblast: Cellular therapy company developing mesenchymal stem cell (MSC) products. Comparable to Royan on the MSC product line and the therapeutic-side of the cord blood / MSC business.

Others

• BioLife Solutions: Supplier of cryopreservation media and cold chain consumables used by cell therapy companies and cord blood banks. Comparable to Royan as an adjacent ecosystem participant in the cryopreservation value chain.

Regional players

• Singapore Cord Blood Bank: Non-profit public cord blood bank operated under Singapore's healthcare system. Comparable in public banking operations and HLA-matching focus, though not a direct competitor in the private consumer market.
• Smart Cells International: UK-headquartered private stem cell bank with international presence. Operates a similar subscription storage model for cord blood and tissue, with a comparable clinical positioning to Royan.
• Cells4Life: UK-based private cord blood and tissue bank. Comparable in service model and product breadth, but operates principally in the UK/Europe rather than the Middle East.

Direct peers

• StemCyte: Operates both private and public cord blood banking globally, including in the Middle East and Asia. Closely matches Royan's dual private/public model and its focus on transplant-grade inventory.
• Cryo-Cell International: One of the largest private U.S. cord blood banks with a multi-decade operating history and a similar subscription-based storage model. Directly comparable to Royan in core service, pricing structure, and target customer (expectant parents).
• ViaCord (PerkinElmer): U.S.-based private cord blood and cord tissue bank owned by PerkinElmer. Comparable to Royan in offering private storage of multiple birth-related stem cell sources to expectant parents, with a long-standing brand presence.
• LifebankUSA (Celularity): U.S. cord blood and placenta-derived banking, now part of Celularity's cellular therapeutics platform. Directly comparable to Royan on placenta banking and the broader strategy of monetizing birth by-products beyond cord blood alone.
• Cord Blood Registry (CBR) / California Cryobank: Largest private cord blood bank in the United States, now part of California Cryobank Life Sciences. Directly comparable to Royan in scale, multi-product storage (cord blood, cord tissue), and cord blood + cellular therapy expansion playbook.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/RoyanCordBloodBank
• LinkedInlinkedin.com/company/royan-stem-cell-technology-co-

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Royan Stem Cell Technology Company